Long-term clinical outcome of 103 patients with acromegaly after pituitary surgery.

ABSTRACT:

Purpose

Acromegaly is a rare disease that can be challenging to treat due to residual pituitary adenoma after surgery or variable response to medical treatments. The primary aim of the study was to evaluate the path of treatment and long-term outcome of acromegaly after pituitary surgery.

Methods

Patients with acromegaly who had undergone surgery for a growth hormone-producing pituitary neuroendocrine tumor also known as a pituitary adenoma, at Sahlgrenska University Hospital between 1994 and 2019 were included in the study. Medical records from diagnosis to the end of study (November 2022) were reviewed for surgical outcome and treatment patterns related to acromegaly.

Results

In the cohort of 103 patients, 111 surgeries were performed. Mean follow-up duration was 12

SUBMITTER: Pennlund A 

PROVIDER: S-EPMC11846723 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature